Rhythm Pharmaceuticals, Inc. RYTM Enterprise value

Enterprise value at other companies

Eli LillyLLY

$1.12T+51.8%

Aardvark Therapeutics, Inc.AARD

$20.15M—

Viking TherapeuticsVKTX

$3.81B-14.5%

Mirum Pharmaceuticals, Inc.MIRM

$6.89B+193%

TG TherapeuticsTGTX

$8.68B+43.6%

Neurocrine BiosciencesNBIX

$13.41B+18.5%

FAQ

What is Rhythm Pharmaceuticals, Inc.'s enterprise value?

Rhythm Pharmaceuticals, Inc. (RYTM) reported enterprise value of $5.99B in Q1 2026.

How has Rhythm Pharmaceuticals, Inc.'s enterprise value changed year-over-year?

Rhythm Pharmaceuticals, Inc.'s enterprise value increased by 78.4% year-over-year, from $3.36B to $5.99B.

What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s enterprise value?

Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s enterprise value has grown at a 38.8% compound annual growth rate (CAGR), from $1.4B to $7.2B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.